# PARM1

## Overview
PARM1, or prostate androgen-regulated mucin-like protein 1, is a gene that encodes a type I transmembrane glycoprotein characterized by its mucin-like properties. This protein is heavily glycosylated and plays a significant role in cellular processes, particularly in the context of androgen regulation and cancer biology. The PARM1 protein is involved in cell proliferation and survival, with its expression being androgen-dependent, especially in prostate tissues. It is implicated in the activation of several key signaling pathways, including ERK1/2, AKT, and STAT3, which are associated with oncogenic processes. The protein's structure, featuring a single transmembrane domain and a cytoplasmic tail with a tyrosine-sorting signal, is crucial for its intracellular trafficking and function. PARM1's involvement in various cancers, such as prostate and colorectal cancer, highlights its potential as a therapeutic target and its significance in cancer progression and cellular stress responses (Charfi2013Characterization; Fladeby2007Human; Liu2019Neurexophilin).

## Structure
The PARM1 protein, encoded by the human PARM1 gene, is a mucin-like type I transmembrane glycoprotein. It consists of 310 amino acids and features a single transmembrane domain, with a cytoplasmic C-terminal end and an extracellular N-terminal end rich in mucin-like glycosylations (Fladeby2007Human). The extracellular domain is heavily glycosylated, containing both N-linked and O-linked glycans, which contribute to more than 60% of its relative molecular mass (Fladeby2007Human). The protein also includes a signal peptide and a tyrosine-sorting signal, 287 YGRL 290, in its cytoplasmic tail, which is crucial for intracellular trafficking (Fladeby2007Human).

The protein's structure is characterized by a high content of serine, threonine, and proline residues, typical of mucins, and it contains multiple sites for N-glycosylation, mucin-type O-glycosylation, and glycosaminoglycan attachment (Fladeby2007Human). The transmembrane domain is essential for its localization within the Golgi and endocytic pathways, while the cytoplasmic tail may inhibit plasma membrane localization (Charfi2013Characterization). The protein's glycosylation and structural motifs suggest a role in cell signaling and adhesion, with implications in cancer development and progression (Charfi2013Characterization; Fladeby2007Human).

## Function
The human PARM1 gene encodes a mucin-like protein involved in various cellular processes, particularly in the context of androgen regulation. PARM1 is characterized by its role in cell proliferation and survival, especially in prostate tissue. It is a highly glycosylated type I transmembrane protein that localizes to the Golgi, plasma membrane, and early endocytic pathway, but not lysosomes, indicating its involvement in the early endocytic pathway (Fladeby2007Human). The protein's intracellular trafficking and localization are mediated by a tyrosine-sorting signal in its cytoplasmic tail, which is crucial for its function in cellular processes (Charfi2013Characterization).

PARM1 is implicated in activating several signaling pathways, including ERK1/2, AKT, and STAT3, which are associated with cell proliferation and survival (Charfi2013Characterization). These pathways contribute to its potential oncogenic role, as PARM1 can induce anchorage-independent growth, a hallmark of cancer cells (Charfi2013Characterization). In healthy cells, PARM1's expression is androgen-dependent, with increased levels in prostate cancer cells upon androgen stimulation, suggesting its role in normal prostate biology and response to hormonal changes (Fladeby2007Human). The protein's mucin-like properties, including a high content of sulfated sugars, suggest its involvement in cell proliferation and tumor growth (Fladeby2007Human).

## Clinical Significance
PARM1 has been implicated in various diseases, particularly in the context of cancer. In prostate cancer, PARM1 expression is regulated by androgens, with increased expression observed in androgen-dependent prostate cancer cells. This suggests a role in cancer growth and progression, potentially through its proliferative effects on prostate cancer cells (Fladeby2007Human). PARM1 is also associated with telomerase activity regulation, which is crucial for cell immortalization, a characteristic of cancer cells. This regulation may contribute to the survival and proliferation of cancerous or pre-cancerous cells in the prostate (Cornet2003Prostatic).

In colorectal cancer, PARM1 is identified as a potential tumor suppressor. Its low expression in tumor tissues correlates with larger tumor size and poorer clinical outcomes, suggesting that PARM1 may inhibit cancer cell proliferation and induce apoptosis through the BMP/Smad signaling pathway (Liu2019Neurexophilin).

PARM1 is also involved in T-CD8+ leukemias, where it is upregulated and contributes to oncogenic processes by enhancing cell proliferation and activating key signaling pathways such as ERK1/2, AKT, and STAT3 (Charfi2013Characterization).

## Interactions
PARM1, also known as prostate androgen-regulated mucin-like protein 1, is involved in several protein interactions that influence its function in cellular processes. One notable interaction is with TRIP-1 (TGF-b receptor interacting protein 1), which suggests a role in the regulation of proliferation and differentiation, particularly in prostate cancer cells (Fladeby2007Human). This interaction may be part of a mechanism through which PARM1 influences cell growth and proliferation.

PARM1 is also implicated in the activation of key signaling pathways, including ERK1/2, AKT, and STAT3, which are crucial for cell proliferation and are often activated in cancers (Charfi2013Characterization). These interactions suggest that PARM1 may function as a receptor or transporter, potentially forming part of a multiprotein complex that modulates these pathways.

In cardiac myocytes, PARM1 is involved in the endoplasmic reticulum (ER) stress response, where it interacts with ER stress sensors such as PERK and ATF6. This interaction is crucial for maintaining prosurvival signaling during ER stress, highlighting PARM1's protective role against apoptosis in cardiac cells (Isodono2010PARM1). These interactions underscore PARM1's multifaceted role in cellular stress responses and oncogenic processes.


## References


[1. (Charfi2013Characterization) Cyndia Charfi, Louis-Charles Levros, Elsy Edouard, and Eric Rassart. Characterization and identification of parm-1 as a new potential oncogene. Molecular Cancer, July 2013. URL: http://dx.doi.org/10.1186/1476-4598-12-84, doi:10.1186/1476-4598-12-84. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-12-84)

[2. (Isodono2010PARM1) Koji Isodono, Tomosaburo Takahashi, Hiroko Imoto, Naohiko Nakanishi, Takehiro Ogata, Satoshi Asada, Atsuo Adachi, Tomomi Ueyama, Hidemasa Oh, and Hiroaki Matsubara. Parm-1 is an endoplasmic reticulum molecule involved in endoplasmic reticulum stress-induced apoptosis in rat cardiac myocytes. PLoS ONE, 5(3):e9746, March 2010. URL: http://dx.doi.org/10.1371/journal.pone.0009746, doi:10.1371/journal.pone.0009746. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0009746)

[3. (Cornet2003Prostatic) Anne M. Cornet, Emmanuel Hanon, Eric R. Reiter, Marc Bruyninx, Viet Ha Nguyen, Benoît R. Hennuy, Georges P. Hennen, and Jean L. Closset. Prostatic androgen repressed message‐1 (parm‐1) may play a role in prostatic cell immortalisation. The Prostate, 56(3):220–230, May 2003. URL: http://dx.doi.org/10.1002/pros.10254, doi:10.1002/pros.10254. This article has 17 citations.](https://doi.org/10.1002/pros.10254)

[4. (Liu2019Neurexophilin) Ya‐Rui Liu, Yang Hu, Ying Zeng, Zhi‐Xing Li, Hai‐Bo Zhang, Jun‐Li Deng, and Guo Wang. Neurexophilin and pc‐esterase domain family member 4 (nxpe4) and prostate androgen‐regulated mucin‐like protein 1 (parm1) as prognostic biomarkers for colorectal cancer. Journal of Cellular Biochemistry, 120(10):18041–18052, July 2019. URL: http://dx.doi.org/10.1002/jcb.29107, doi:10.1002/jcb.29107. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.29107)

[5. (Fladeby2007Human) Cathrine Fladeby, Shailly N. Gupta, Nicolas Barois, Petri I. Lorenzo, Jeremy C. Simpson, Fahri Saatcioglu, and Oddmund Bakke. Human parm‐1 is a novel mucin‐like, androgen‐regulated gene exhibiting proliferative effects in prostate cancer cells. International Journal of Cancer, 122(6):1229–1235, November 2007. URL: http://dx.doi.org/10.1002/ijc.23185, doi:10.1002/ijc.23185. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.23185)